
View larger version (88K):
[in a new window]
|
Fig. 1. Characterisation of antibodies against Bub1 and BubR1. (A and B) Protein extracts from BHK cells ectopically expressing either GST-mBub1 (lanes 1, 5, 9 and 13) or GST-BubR1 (lanes 2, 6, 10 and 14), TA-HeLa cells (lanes 3, 7, 8, 11, 15 and 16) and mouse L929 cells (lane 4 and 12) analysed by western blotting with (A) the anti-Bub1 antibodies 4B12 (mouse monoclonal) and SB1.3 (sheep polyclonal) and (B) the anti-BubR1 antibodies 5F9 (mouse monoclonal) and SBR1.1 (sheep polyclonal). Where indicated, HeLa cells were either asynchronous () or treated with 0.2 µg/ml nocodazole for 16 hours (+). (C) Immunofluorescence images of DLD-1 cells stained with monoclonal (red) and polyclonal (green) antibodies against Bub1 (left column) and BubR1 (middle column). The cells were also stained with Hoechst to identify the chromosomes (blue, right column). (i, iii) Late prophase cells showing colocalisation of Bub1 and BubR1 at kinetochores. (ii, iv) Fields showing multiple mitotic cells. Note that in anaphase cells (arrowheads), Bub1 and BubR1 are virtually undetectable at kinetochores yet at prometaphase (ii) and metaphase (iv) cells (arrows) kinetochore-associated Bub1 and BubR1 is clearly detectable. Note also that in early prophase (double arrowhead) Bub1 localises to kinetochores before BubR1.
|